インターベンショナル神経機器市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

インターベンショナル神経機器市場は、2023年に20億2,000万米ドルと評価され、2024年には21億7,000万米ドルに達すると予測され、CAGR 8.97％で成長し、2030年には36億9,000万米ドルに達すると予測されています。

インターベンショナル神経機器の対象範囲には、脳、脊髄、末梢神経系に影響を及ぼす疾患の診断と治療を目的とした医療機器が含まれます。これらの医療機器には、神経血栓除去装置、脳血管形成術およびステント留置システム、塞栓防止装置、支持カテーテルなどが含まれ、動脈瘤、動静脈奇形、虚血性脳卒中などの疾患の治療に不可欠です。これらの機器の必要性は、世界人口の高齢化と神経疾患の有病率の増加から生じており、従来の方法に比べて回復が早く合併症が少ない低侵襲治療の進歩を後押ししています。これらの機器は病院、外来手術センター、神経学専門クリニックで利用されており、技術の進歩や神経学的健康に対する意識の高まりが需要を後押ししています。主な成長要因としては、先端画像技術の急速な発展、新興国市場でのヘルスケア支出の増加、政府の支援政策などが挙げられます。しかし、高コスト、厳しい規制要件、未発達地域における最先端技術へのアクセス制限などの課題が、市場拡大を阻害する可能性があります。こうした課題にもかかわらず、機器開発における人工知能とロボティクスの統合、精度と効率性の提供、個々の患者プロファイルに合わせた介入を行う個別化医療アプローチにチャンスがあります。材料と装置の小型化における革新は、患者の外傷を最小限に抑え、手技の有効性を高めることで、事業成長のさらなる可能性を提示します。企業は、技術的・規制的ハードルを克服するため、戦略的パートナーシップや共同研究に注力することが推奨されます。市場は厳しい競争と継続的な技術革新の必要性を特徴としており、企業は先を行くために研究開発に投資する必要があります。特にアジア太平洋やラテンアメリカのような拡大する地域では、患者のニーズや新たなヘルスケア動向を深く理解することが、アンメット・クリニカル・ニーズを開拓する上で極めて重要です。

市場力学：急速に進化するインターベンショナル神経機器市場の主要市場インサイトを公開

インターベンショナル神経機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 脳動脈瘤および神経疾患の有病率の増加
  • 最小侵襲手術への大きな傾斜
  • 介入神経学機器における先端技術の統合
• 市場抑制要因
  • 介入神経学機器の高コスト
• 市場機会
  • 神経治療のための継続的な研究開発活動
  • 革新的な製品の出現とインターベンショナル神経機器の承認
• 市場の課題
  • 世界中の神経外科医の不足

ポーターのファイブフォース：インターベンショナル神経機器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：インターベンショナル神経機器市場における外部からの影響の把握

外部マクロ環境要因は、インターベンショナル神経機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析インターベンショナル神経機器市場における競合情勢の把握

インターベンショナル神経機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスインターベンショナル神経機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、インターベンショナル神経機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨インターベンショナル神経機器市場における成功への道筋を描く

インターベンショナル神経機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 脳動脈瘤と神経疾患の増加
    • 低侵襲手術への強い傾向
    • 介入神経学機器における先進技術の統合
  • 抑制要因
    • 介入神経学機器の高コスト
  • 機会
    • 神経治療に関する継続的な研究開発活動
    • インターベンショナル神経機器の革新的な新製品と承認
  • 課題
    • 世界中で脳神経外科医が不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 インターベンショナル神経機器市場：タイプ別

• 動脈瘤コイル塞栓術用器具
  • 塞栓コイル
  • 流れ転換装置
  • 液体塞栓デバイス
• 脳脊髄液管理装置
• 神経血栓除去装置
  • 血栓除去装置
  • スネア
  • 吸引・吸引装置
• サポートデバイス
  • マイクロカテーテル
  • マイクロガイドワイヤー

第7章 インターベンショナル神経機器市場：エンドユーザー別

• 外来診療センター
• 病院
• 神経科クリニック

第8章 南北アメリカのインターベンショナル神経機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のインターベンショナル神経機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのインターベンショナル神経機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acandis GmBH
• BALT Group
• Evasc
• Imperative Care
• Integer Holding Corporation
• Johnson & Johnson Services, Inc.
• Kaneka Corp.
• Medtronic PLC
• Microport Scientific Corporation
• Penumbra Inc. by SGS Group
• Perflow Medical
• Phenox GmBH
• Sensome
• Stryker Corporation
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. INTERVENTIONAL NEUROLOGY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. INTERVENTIONAL NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. INTERVENTIONAL NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTERVENTIONAL NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTERVENTIONAL NEUROLOGY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SNARES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION & ASPIRATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY MICRO GUIDE WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 47. CANADA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. CHINA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. INDIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. ITALY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 185. POLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. QATAR INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING & EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM INTERVENTIONAL NEUROLOGY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. INTERVENTIONAL NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. INTERVENTIONAL NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Interventional Neurology Devices Market was valued at USD 2.02 billion in 2023, expected to reach USD 2.17 billion in 2024, and is projected to grow at a CAGR of 8.97%, to USD 3.69 billion by 2030.

The scope of interventional neurology devices encompasses medical equipment designed to diagnose and treat disorders affecting the brain, spinal cord, and peripheral nervous system. These devices include neurothrombectomy devices, cerebral angioplasty and stenting systems, embolic protection devices, and support catheters, essential for addressing conditions like aneurysms, arteriovenous malformations, and ischemic strokes. The necessity for these devices arises from an aging global population and increasing prevalence of neurological disorders, driving advances in minimally invasive treatments that offer faster recovery and reduced complications compared to conventional methods. They are utilized in hospitals, ambulatory surgical centers, and specialized neurology clinics, where demand is fueled by technological advancements and growing awareness of neurological health. Key growth factors include the rapid development of advanced imaging techniques, increasing healthcare expenditure in emerging markets, and supportive government policies. However, challenges such as high costs, stringent regulatory requirements, and limited access to cutting-edge technology in underdeveloped regions may impede market expansion. Despite these challenges, opportunities lie in the integration of artificial intelligence and robotics in device development, offering precision and efficiency, and personalized medicine approaches, tailoring interventions to individual patient profiles. Innovations in materials and device miniaturization present further potential for business growth, minimizing patient trauma and enhancing procedural efficacy. Companies are recommended to focus on strategic partnerships and collaborative research to overcome technical and regulatory hurdles. The market is characterized by stiff competition and the necessity for ongoing innovation, with businesses needing to invest in R&D to stay ahead. A deep understanding of patient needs and emerging healthcare trends is pivotal for tapping into unmet clinical needs, particularly in expanding regions such as Asia-Pacific and Latin America.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Interventional Neurology Devices Market

The Interventional Neurology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of brain aneurysm and neurological disorders
  • Significant inclination towards the minimal invasive surgeries
  • Integration of advanced technologies in Intervention neurology devices
• Market Restraints
  • Associated high cost of intervention neurology devices
• Market Opportunities
  • Ongoing research and development activities for neuro therapy
  • Emerging innovative products and approvals for interventional neurology devices
• Market Challenges
  • Dearth of neurosurgeons across the world

Porter's Five Forces: A Strategic Tool for Navigating the Interventional Neurology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Interventional Neurology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Interventional Neurology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Interventional Neurology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Interventional Neurology Devices Market

A detailed market share analysis in the Interventional Neurology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Interventional Neurology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Interventional Neurology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Interventional Neurology Devices Market

A strategic analysis of the Interventional Neurology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Interventional Neurology Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmBH, BALT Group, Evasc, Imperative Care, Integer Holding Corporation, Johnson & Johnson Services, Inc., Kaneka Corp., Medtronic PLC, Microport Scientific Corporation, Penumbra Inc. by SGS Group, Perflow Medical, Phenox GmBH, Sensome, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Interventional Neurology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, and Support Devices. The Aneurysm Coiling & Embolization Devices is further studied across Embolic Coils, Flow Diversion Devices, and Liquid Embolic Devices. The Neurothrombectomy Devices is further studied across CLOT Retrieval Devices, Snares, and Suction & Aspiration Devices. The Support Devices is further studied across Micro Catheters and Micro Guide Wires.
• Based on End-User, market is studied across Ambulatory Care Centers, Hospitals, and Neurology Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of brain aneurysm and neurological disorders
    • 5.1.1.2. Significant inclination towards the minimal invasive surgeries
    • 5.1.1.3. Integration of advanced technologies in Intervention neurology devices
  • 5.1.2. Restraints
    • 5.1.2.1. Associated high cost of intervention neurology devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities for neuro therapy
    • 5.1.3.2. Emerging innovative products and approvals for interventional neurology devices
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of neurosurgeons across the world
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Interventional Neurology Devices Market, by Type

• 6.1. Introduction
• 6.2. Aneurysm Coiling & Embolization Devices
  • 6.2.1. Embolic Coils
  • 6.2.2. Flow Diversion Devices
  • 6.2.3. Liquid Embolic Devices
• 6.3. Cerebrospinal Fluid Management Devices
• 6.4. Neurothrombectomy Devices
  • 6.4.1. CLOT Retrieval Devices
  • 6.4.2. Snares
  • 6.4.3. Suction & Aspiration Devices
• 6.5. Support Devices
  • 6.5.1. Micro Catheters
  • 6.5.2. Micro Guide Wires

7. Interventional Neurology Devices Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Care Centers
• 7.3. Hospitals
• 7.4. Neurology Clinics

8. Americas Interventional Neurology Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Interventional Neurology Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Interventional Neurology Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acandis GmBH
• 2. BALT Group
• 3. Evasc
• 4. Imperative Care
• 5. Integer Holding Corporation
• 6. Johnson & Johnson Services, Inc.
• 7. Kaneka Corp.
• 8. Medtronic PLC
• 9. Microport Scientific Corporation
• 10. Penumbra Inc. by SGS Group
• 11. Perflow Medical
• 12. Phenox GmBH
• 13. Sensome
• 14. Stryker Corporation
• 15. Terumo Corporation